PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Sneezing D012912 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Ehara H [An experimental study on antitumor effect of prostaglandin D2]. 1989 Nihon Geka Gakkai Zasshi pmid:2796985
Fukuda T [Trend in chemical mediator research in asthma and its application for asthma treatment]. 2003 Nihon Kokyuki Gakkai Zasshi pmid:14531291
Hoshi A et al. [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. 1992 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1507684
Yamada K [The effect of prostaglandin D2 on rat testicular testosterone levels]. 1989 Nihon Naibunpi Gakkai Zasshi pmid:2591605
Suzuki H et al. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. 1986 Nihon Naibunpi Gakkai Zasshi pmid:3465609
Kudo M et al. [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells]. 1990 Nihon Naibunpi Gakkai Zasshi pmid:1962750
Fujitani Y et al. [Sleep-promoting substances]. 1998 Nihon Ronen Igakkai Zasshi pmid:10064966
Shimojima T et al. [Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]. 1987 Nihon Shishubyo Gakkai Kaishi pmid:2851629
Goto H [Quantitative determination of prostaglandin D2 in the rat gastric mucosa by high performance liquid chromatography]. 1987 Nihon Shokakibyo Gakkai Zasshi pmid:3473244
Shiroma T et al. [Production and metabolism of prostaglandin D2 by cultured chick retinal pigment epithelial cells]. 1996 Nippon Ganka Gakkai Zasshi pmid:8741332
Mezawa A [Nasal response to chemical mediators in nasal allergy]. 1988 Nippon Jibiinkoka Gakkai Kaiho pmid:3199260
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Kariya T et al. Platelet abnormality with no response to PGD2 in a patient with metastatic pancreas carcinoma and myeloproliferative disorder. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3473883
Masuko-Hongo K [Role of prostaglandins in rheumatoid arthritis]. 2005 Nippon Rinsho pmid:15799333
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Uehara Y [Prostaglandin D2]. 1999 Nippon Rinsho pmid:10635955
Uehara Y [Prostaglandin D2 and related substances]. 2010 Nippon Rinsho pmid:20960740
Fukushima S et al. [Pharmaceutical and pharmacological development of antitumor prostaglandins]. 1998 Nippon Rinsho pmid:9549353
Uehara Y [Prostaglandin D2]. 2005 Nippon Rinsho pmid:16149440
Hayaishi O [Prostaglandins and sleep]. 1998 Nippon Rinsho pmid:9503823
Urade Y [Gene engineering studies on sleep]. 1998 Nippon Rinsho pmid:9503856
Uchizono K [Studies of sleep inducing substance]. 1984 Nippon Rinsho pmid:6384575
Urade Y [Molecular mechanisms of insomnia]. 2009 Nippon Rinsho pmid:19768929
Saito H [Mast cells]. 2005 Nippon Rinsho pmid:15861652
Fukushima M [Prostaglandin J2--anti-tumor activity and mechanism of action]. 1988 Nippon Rinsho pmid:3043050
Nagata N and Urade Y [Endogenous sleep-promoting substance]. 2012 Nippon Rinsho pmid:22844810
Kikuchi Y et al. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2313142
Kikuchi Y et al. Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro. 1987 Nippon Sanka Fujinka Gakkai Zasshi pmid:3479504
Hirai H [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. 2004 Nippon Yakurigaku Zasshi pmid:14695454
Uehara Y [PGD(2)/L-PGDS system in hypertension and renal injury]. 2004 Nippon Yakurigaku Zasshi pmid:14695455
Miwa Y et al. Physiology and pharmacology of the prostaglandin J2 family. 2004 Nippon Yakurigaku Zasshi pmid:14695456
Arai I [Role of cutaneous prostaglandin D2 production on scratching dermatitis in mice]. 2006 Nippon Yakurigaku Zasshi pmid:17167214
Tanaka H and Nagai H [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation]. 2001 Nippon Yakurigaku Zasshi pmid:11338375
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Urade Y [New aspects on prostaglandin D synthases]. 1997 Nippon Yakurigaku Zasshi pmid:9503406
Ushikubi F and Narumiya S [The roles of the prostanoids played in the body]. 2002 Nippon Yakurigaku Zasshi pmid:11979724
Sonoki H et al. [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. 1988 Nippon Yakurigaku Zasshi pmid:3163668
Onoe H [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. 1998 Nippon Yakurigaku Zasshi pmid:10202759
Satoh T [Neurotrophin-like low molecular weight compounds]. 2002 Nippon Yakurigaku Zasshi pmid:12491808
González E et al. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. 2002 Nitric Oxide pmid:11890746
Takeshima Y [Development of novel therapeutic approaches for Duchenne muscular dystrophy]. 2014 No To Hattatsu pmid:24738186
Urade Y and Mohri I [Sleep and brain function]. 2006 No To Hattatsu pmid:16986732
Nakamura O et al. [Antineoplastic effect of prostaglandins on human glioma in athymic nude mice]. 1988 No To Shinkei pmid:3179087
Urade Y and Eguchi N [Sleep substances]. 2003 No To Shinkei pmid:12649899
Marone G et al. The human heart as a shock organ in anaphylaxis. 2004 Novartis Found. Symp. pmid:15025396
Corren J et al. Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. 2008 Nutr J pmid:18625073
Fajas L et al. PPAR gamma: an essential role in metabolic control. 2001 Nutr Metab Cardiovasc Dis pmid:11383325
Juman S et al. Effects of long-term oral administration of arachidonic acid and docosahexaenoic acid on the immune functions of young rats. 2013 Nutrients pmid:23760060
Schäffler A et al. Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin". 2007 Obesity (Silver Spring) pmid:17299102
Menon R et al. Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. 2011 Obstet Gynecol pmid:21691170
Norwitz ER et al. Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. 1992 Obstet Gynecol pmid:1495703
Burgermeister E et al. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. 2003 Oncogene pmid:12813462
Kar R et al. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. 2009 Oncogene pmid:19448671
Kim DH et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. 2010 Oncogene pmid:20208557
Crabb SJ et al. BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. 2008 Oncol. Rep. pmid:18288403
Takashima T et al. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. 2005 Oncol. Rep. pmid:15756430
Servidei T et al. The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. 2004 Oncol. Res. pmid:15301425
Walther U et al. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway. 2016 Oncotarget pmid:26863638
Yen CC et al. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. 2014 Oncotarget pmid:24566468
Yuan J et al. M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway. 2017 Oncotarget pmid:28423639
Ogino N et al. Phagocytic activity of cultured retinal pigment epithelial cells from chick embryo: inhibition by melatonin and cyclic AMP, and its reversal by taurine and cyclic GMP. 1983 Ophthalmic Res. pmid:6136017
Woodward DF et al. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. 1989 Ophthalmic Res. pmid:2626239
Huisingh C and McGwin G Change in prostaglandin expression levels and synthesizing activities. 2013 Ophthalmology pmid:24001535
Rim TH et al. Author reply: To PMID 22858125. 2013 Ophthalmology pmid:24001536
Shim J et al. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. 2012 Ophthalmology pmid:22858125
Sheddan NA and Mulzer J Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. 2006 Org. Lett. pmid:16805562
Brummond KM et al. The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. 2004 Org. Lett. pmid:14723515
Blázovics A et al. [Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. 2004 Orv Hetil pmid:15662752
Fahmi H et al. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1. 2002 Osteoarthr. Cartil. pmid:11869069
Fahmi H et al. 15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. 2002 Osteoarthr. Cartil. pmid:12435328
Ebersberger A et al. Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat. 2011 Pain pmid:21345590
Minami T et al. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. 1994 Pain pmid:7916452
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. 2002 Pancreas pmid:11854617
Hashimoto K et al. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. 2004 Pancreas pmid:15028947
Hashimoto K et al. The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. 2003 Pancreas pmid:12826907
Closa D et al. Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. 1994 Pancreas pmid:7509066
Wang Y et al. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. 2009 Pediatr. Res. pmid:19262292
Uemura S et al. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. 1984 Pediatr. Res. pmid:6596550
Zhao H et al. Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats. 2008 Peptides pmid:18180074
Bai G et al. Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2. 2009 Peptides pmid:19539681
Zhao H et al. Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice. 2008 Peptides pmid:18243414
Shimatsu A et al. Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. 1984 Mar-Apr Peptides pmid:6591147
Peeraully MR et al. Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. 2006 Pflugers Arch. pmid:16924534
Bhattacharya SK and Parmar SS Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism. 1987 Pharm. Res. pmid:2977646
Hagens WI et al. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. 2007 Pharm. Res. pmid:17245650
Eichele K et al. R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. 2009 Pharm. Res. pmid:19015962
Csányi G et al. Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. 2008 May-Jun Pharmacol Rep pmid:18622059
Saito R et al. The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats. 1987 Pharmacol. Biochem. Behav. pmid:2883669
Hollingsworth EB and Patrick GA The effects produced by prostaglandin D2 on serotonin turnover and release and tryptophan uptake. 1985 Pharmacol. Biochem. Behav. pmid:2581275
Nielsen JA and Sparber SB Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. 1985 Pharmacol. Biochem. Behav. pmid:3860881
Hollingsworth EB and Patrick GA Involvement of the serotonergic system in the prolongation of pentobarbital sleeping time produced by prostaglandin D2. 1985 Pharmacol. Biochem. Behav. pmid:2859604
D'Onofrio C et al. The antiproliferative effect of prostaglandin A and J on HTLV-I transformed cells is associated with induction of a heat-shock protein. 1990 Sep-Oct Pharmacol. Res. pmid:2284244
Reyes-Martin P et al. Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. 2007 Pharmacol. Res. pmid:17291778
Reyes-Martin P et al. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. 2008 Pharmacol. Res. pmid:18456507
Schuligoi R et al. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. 2010 Pharmacology pmid:20559016
Prenn C et al. CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine. 2008 Pharmacology pmid:18212515
Tanaka H et al. Possible involvement of prostaglandins F(2alpha) and D(2) in acetylcholine-induced positive inotropy in isolated mouse left atria. 2003 Pharmacology pmid:12571412
Azuma Y et al. Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. 2004 Pharmacology pmid:15240994
Hayaishi O Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. 2000 Philos. Trans. R. Soc. Lond., B, Biol. Sci. pmid:10724461
Murphy PJ et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. 1994 Physiol. Behav. pmid:8047572